Literature DB >> 20063514

Systemic loxoscelism confirmation by bite-site skin surface: ELISA.

William V Stoecker1, Gary S Wasserman, David A Calcara, Jonathan A Green, Karen Larkin.   

Abstract

We report here a case of systemic loxoscelism, confirmed by bite-site skin surface swab. Features of systemic loxoscelism present in this case included debilitating symptoms, a classic local bite-site reaction, hemolysis causing loss of approximately 15% of the blood volume within 72 hours, and a symptomatic exanthem. A skin surface ELISA test was used to confirm the presence of venom. This test enables confirmation of cases of loxoscelism for which no spider is found.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20063514      PMCID： PMC3160791     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  17 in total

1.  Brown recluse spider bites: a common cause of necrotic arachnidism.

Authors:  G D Hobbs; R E Harrell
Journal:  Am J Emerg Med       Date:  1989-05       Impact factor: 2.469

2.  Dapsone treatment of a brown recluse bite.

Authors:  L E King; R S Rees
Journal:  JAMA       Date:  1983-08-05       Impact factor: 56.272

3.  [Early treatment of loxoscelism with corticosteroids].

Authors:  M Kahana; M Ronnen; M Schewach-Millet
Journal:  Harefuah       Date:  1984-06-15

Review 4.  Necrotic arachnidism.

Authors:  H H Sams; C A Dunnick; M L Smith; L E King
Journal:  J Am Acad Dermatol       Date:  2001-04       Impact factor: 11.527

5.  Nineteen documented cases of Loxosceles reclusa envenomation.

Authors:  H H Sams; S B Hearth; L L Long; D C Wilson; D H Sanders; L E King
Journal:  J Am Acad Dermatol       Date:  2001-04       Impact factor: 11.527

6.  Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil.

Authors:  Ceila Maria Sant'Ana Málaque; Jaime Enrique Castro-Valencia; João Luiz Costa Cardoso; Francisco Oscar de Siqueira Françca; Kátia Cristina Barbaro; Hui Wen Fan
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2002 May-Jun       Impact factor: 1.846

7.  Search of intravascular hemolysis in patients with the cutaneous form of loxoscelism.

Authors:  P Morena; K Nonoyama; J L Cardoso; O C Barretto
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1994 Mar-Apr       Impact factor: 1.846

8.  Dapsone in the treatment of presumed brown recluse spider bite of the eyelid.

Authors:  R E Wesley; W H Ballinger; L W Close; A M Lay
Journal:  Ophthalmic Surg       Date:  1985-02

9.  Dapsone or electric shock therapy of brown recluse spider envenomation?

Authors:  S M Barrett; M Romine-Jenkins; D E Fisher
Journal:  Ann Emerg Med       Date:  1994-07       Impact factor: 5.721
View more
  5 in total

1.  Obtundation and Myocardial Infarction in a Case of Systemic Loxoscelism.

Authors:  Karen D Schilli; Ryan K Rader; Katie S Payne; Jonathan A Green; William V Stoecker
Journal:  Mo Med       Date:  2014 Mar-Apr

2.  Viscerocutaneous Loxoscelism in an Adult with Acute Generalized Exanthematous Pustulosis.

Authors:  Mark Mueller; Emily Doucette; Seth Freeman; Amy Williams; Erik Lindbloom
Journal:  Mo Med       Date:  2014 Mar-Apr

Review 3.  Scorpionism by Hemiscorpius spp. in Iran: a review.

Authors:  Rouhullah Dehghani; Fatemeh Kamiabi; Malihe Mohammadi
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-03-02

4.  Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.

Authors:  Eric A Gehrie; Hui Nian; Pampee P Young
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 5.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.